English
简体中文
Total: £ 56.28
2026-02-03 | Pages: 104 | Tables: 107
The global Paediatric Influenza Treatment market was valued at US$ 608 million in 2025 and is anticipated to reach US$ 770 million by 2032, at a CAGR of 3.5% from 2026 to 2032.Pediatric influenza treatment involves specialized medical care and medica...
2026-02-03 | Pages: 143 | Tables: 160
The global Point of Care OTC Product market was valued at US$ 20370 million in 2025 and is anticipated to reach US$ 32920 million by 2032, at a CAGR of 7.2% from 2026 to 2032.Point-of-Care (POC) Over-the-Counter (OTC) products are diagnostic tools an...
2026-02-03 | Pages: 154 | Tables: 149
The global Professional POCT product market was valued at US$ 7770 million in 2025 and is anticipated to reach US$ 10530 million by 2032, at a CAGR of 4.5% from 2026 to 2032.Professional Point-of-Care Testing (POCT) products are diagnostic devices us...
2026-02-03 | Pages: 156 | Tables: 144
The global Non-Hospital-Based Point-Of-Care Diagnostic Product market was valued at US$ 13870 million in 2025 and is anticipated to reach US$ 22850 million by 2032, at a CAGR of 7.5% from 2026 to 2032.Non-hospital-based Point-of-Care (POC) diagnostic...
2026-02-03 | Pages: 119 | Tables: 112
The global Point of Care Urine Testing Product market was valued at US$ 3198 million in 2025 and is anticipated to reach US$ 5037 million by 2032, at a CAGR of 6.8% from 2026 to 2032.Point-of-Care (POC) urine testing products are diagnostic devices u...
2026-02-03 | Pages: 151 | Tables: 144
The global Point of Care Blood Testing Product market was valued at US$ 20370 million in 2025 and is anticipated to reach US$ 32920 million by 2032, at a CAGR of 7.2% from 2026 to 2032.Point-of-Care (POC) blood testing products refer to diagnostic to...
2026-02-03 | Pages: 126 | Tables: 132
The global Ocular Tuberculosis Therapeutics market was valued at US$ 527 million in 2025 and is anticipated to reach US$ 728 million by 2032, at a CAGR of 4.8% from 2026 to 2032.Ocular tuberculosis therapeutics refer to treatments specifically design...
2026-02-03 | Pages: 102 | Tables: 102
The global Systemic Autoinflammatory Diseases Drug market was valued at US$ 14940 million in 2025 and is anticipated to reach US$ 20380 million by 2032, at a CAGR of 4.6% from 2026 to 2032.Systemic autoinflammatory disease drugs are medications used ...
2026-02-03 | Pages: 107 | Tables: 104
The global Rare Autoinflammatory Diseases Drug market was valued at US$ 14940 million in 2025 and is anticipated to reach US$ 20380 million by 2032, at a CAGR of 4.6% from 2026 to 2032.Rare autoinflammatory diseases drugs are medications designed to ...
2026-02-03 | Pages: 108 | Tables: 102
The global Rare Inflammatory Disease Treatment market was valued at US$ 14940 million in 2025 and is anticipated to reach US$ 20380 million by 2032, at a CAGR of 4.6% from 2026 to 2032.Rare inflammatory disease treatment refers to specialized therapi...
2026-02-03 | Pages: 138 | Tables: 136
The global End-stage Renal Disease Therapeutics market was valued at US$ 8244 million in 2025 and is anticipated to reach US$ 12410 million by 2032, at a CAGR of 6.1% from 2026 to 2032.End-stage Renal Disease Therapeutics refers to a specialized rang...
2026-02-03 | Pages: 109 | Tables: 116
The global circRNA-LNP Formulation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsca...
2026-02-03 | Pages: 132 | Tables: 127
The global Late Stage Chronic Kidney Disease Therapeutics market was valued at US$ 8244 million in 2025 and is anticipated to reach US$ 12410 million by 2032, at a CAGR of 6.1% from 2026 to 2032.Late-stage chronic kidney disease (CKD) therapeutics re...
2026-02-03 | Pages: 102 | Tables: 105
The global Home Sleep Apnea Testing market was valued at US$ 986 million in 2025 and is anticipated to reach US$ 1593 million by 2032, at a CAGR of 7.2% from 2026 to 2032.Home Sleep Apnea Testing (HSAT) is a diagnostic method that enables individuals...
2026-02-03 | Pages: 137 | Tables: 133
The global Biopharmaceutical Cold Chain Logistics Services market was valued at US$ 19360 million in 2025 and is anticipated to reach US$ 34490 million by 2032, at a CAGR of 8.7% from 2026 to 2032.Biopharmaceutical Cold Chain Logistics Services are s...
